UBS Group Cuts Xylem (NYSE:XYL) Price Target to $152.00

Xylem (NYSE:XYL) had its target price decreased by UBS Group from $155.00 to $152.00 in a research report sent to investors on Thursday, MarketBeat reports. UBS Group currently has a buy rating on the industrial products company’s stock.

XYL has been the subject of several other research reports. Robert W. Baird set a $161.00 target price on shares of Xylem in a report on Wednesday, February 11th. William Blair assumed coverage on shares of Xylem in a report on Monday, January 26th. They set an “outperform” rating for the company. Stifel Nicolaus reduced their target price on shares of Xylem from $178.00 to $175.00 and set a “buy” rating for the company in a report on Wednesday, February 11th. TD Cowen reissued a “hold” rating on shares of Xylem in a report on Monday, February 23rd. Finally, Weiss Ratings lowered shares of Xylem from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, April 6th. Nine equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $155.31.

Xylem Trading Down 0.5%

Shares of Xylem stock opened at $128.75 on Thursday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.62 and a quick ratio of 1.28. The firm has a fifty day moving average price of $126.39 and a 200 day moving average price of $137.15. Xylem has a 1 year low of $105.73 and a 1 year high of $154.27. The stock has a market cap of $31.30 billion, a PE ratio of 32.84, a price-to-earnings-growth ratio of 1.84 and a beta of 1.18.

Xylem (NYSE:XYL) last issued its earnings results on Tuesday, February 10th. The industrial products company reported $1.42 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.42. Xylem had a net margin of 10.59% and a return on equity of 11.11%. During the same quarter in the previous year, the firm earned $1.18 earnings per share. The company’s quarterly revenue was up 6.3% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.350-5.560 EPS. Equities research analysts predict that Xylem will post 4.65 earnings per share for the current year.

Xylem Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 24th. Investors of record on Tuesday, February 24th were given a dividend of $0.43 per share. This is a boost from Xylem’s previous quarterly dividend of $0.40. This represents a $1.72 annualized dividend and a yield of 1.3%. The ex-dividend date was Tuesday, February 24th. Xylem’s dividend payout ratio (DPR) is 43.88%.

Xylem announced that its board has approved a stock buyback plan on Wednesday, February 25th that permits the company to buyback $1.50 billion in outstanding shares. This buyback authorization permits the industrial products company to buy up to 4.8% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s board believes its shares are undervalued.

Institutional Trading of Xylem

Several hedge funds and other institutional investors have recently added to or reduced their stakes in XYL. AQR Capital Management LLC grew its position in Xylem by 14.4% during the first quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock valued at $3,645,000 after buying an additional 3,900 shares during the period. NewEdge Advisors LLC grew its position in shares of Xylem by 3.3% in the first quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock valued at $496,000 after purchasing an additional 132 shares during the period. Empowered Funds LLC grew its position in shares of Xylem by 56.1% in the first quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock valued at $1,037,000 after purchasing an additional 3,120 shares during the period. Arrowstreet Capital Limited Partnership grew its position in shares of Xylem by 97.6% in the second quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company’s stock valued at $1,442,000 after purchasing an additional 5,509 shares during the period. Finally, EverSource Wealth Advisors LLC grew its position in shares of Xylem by 114.0% in the second quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company’s stock valued at $154,000 after purchasing an additional 635 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.